Swift Run Capital - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 15 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Swift Run Capital ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$17,000
+240.0%
20,000
+37.5%
0.03%
+385.7%
Q1 2020$5,000
-28.6%
14,5450.0%0.01%
-22.2%
Q4 2019$7,000
-74.1%
14,5450.0%0.01%
-64.0%
Q3 2019$27,000
-34.1%
14,5450.0%0.02%
-34.2%
Q2 2019$41,000
-24.1%
14,5450.0%0.04%
-24.0%
Q1 2019$54,000
+86.2%
14,5450.0%0.05%
+61.3%
Q4 2018$29,00014,5450.03%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Yu Fan 89,848$27,0000.31%
Virtu Financial LLC 151,310$46,0000.01%
Strategic Asset Management, LLC 2,000$1,0000.00%
Frontier Wealth Management LLC 25,000$8,0000.00%
St. Johns Investment Management Company, LLC 2$00.00%
UBS Group AG 52,652$16,0000.00%
OSAIC HOLDINGS, INC. 29,669$9,0000.00%
BANK OF AMERICA CORP /DE/ 190$00.00%
WELLS FARGO & COMPANY/MN 7,145$2,0000.00%
NORTHERN TRUST CORP 200,949$61,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders